synvoma offers an intelligent detection platform for cardiac toxicity screening, positioning the company within the pre-clinical research segment of the pharmaceutical industry. It sells into North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa, though further company details are not disclosed in available records.
コメントはありません。
評価とコメントを残す